Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-02-23 @ 4:55 AM
Study NCT ID:
NCT05814666
Status:
RECRUITING
Last Update Posted:
2024-12-31
First Post:
2023-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Sponsor:
Flamingo Therapeutics NV
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HNSCC | View |
Keywords: